World stocks decline amid sour economic data, ASX futures down 28 points

Published 31-JUL-2020 09:39 A.M.


1 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

US stocks traded mostly lower overnight while oil prices fell as government data highlighted the deep economic impacts of the pandemic.

President Donald Trump added to market uncertainty after announcing that the US elections may be postponed, however he faced an immediate pushback by top Republicans.

On the other side of the Atlantic, European markets fell sharply as poor GDP data in Germany added to the subdued mood, with the Dax falling 3.5% as all 30 companies traded in the red. UK shares followed the market lower.

ASX futures have settled 28 points lower after most markets retreated overnight.

European stocks fall sharply

US markets were somewhat mixed as gains in technology offset broader market declines, however Europe experienced a bloodbath.

The STOXX Europe 600 index ended the day 2.16% lower as most sub-indices declined. The FTSE 100 fell 2.31% to 5,989.99 points while the DAX dropped 3.45% to 12,379.65 points.

US GDP fell a staggering 32.9% annualised rate last quarter, the deepest decline since the government started compiling data. While many analysts forecast such a decline, the market as does not seem to be too bothered by these results.

The S&P 500 fell 0.38% and the Dow Jones declined 0.85%. The Nasdaq rose 0.43% after tech giants including Apple, Facebook or Amazon reported strong earnings results.

Asia-Pacific kicked the day off higher but gains were undone as trading progressed. Japan declined 0.26% and the Hang Seng fell 0.69%.

The Australian share market bucked the trend and finished in the black on Thursday with the ASX 200 benchmark index climbing 0.74% to 6,051.1 points.

The MSCI world equity index fell 2.97 points or 0.53%, to 552.5.

Gold prices retreated from all-time highs and settled at US$1,947.4, still near records. Silver dipped almost 3% after a strong rally in recent weeks.

Most oil contracts fell as WTI crude oil tumbled 2.28% to US$40.33, but Brent managed to eke out a small gain.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.


Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free